0001217234-24-000035.txt : 20240409 0001217234-24-000035.hdr.sgml : 20240409 20240409174209 ACCESSION NUMBER: 0001217234-24-000035 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240201 FILED AS OF DATE: 20240409 DATE AS OF CHANGE: 20240409 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Johnson Alexander L CENTRAL INDEX KEY: 0001617150 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36536 FILM NUMBER: 24833697 MAIL ADDRESS: STREET 1: C/O DIADEXUS, INC. STREET 2: 349 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CareDx, Inc. CENTRAL INDEX KEY: 0001217234 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 943316839 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8000 MARINA BLVD STREET 2: 4TH FLOOR CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 415-287-2300 MAIL ADDRESS: STREET 1: 8000 MARINA BLVD STREET 2: 4TH FLOOR CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: XDx, Inc. DATE OF NAME CHANGE: 20071010 FORMER COMPANY: FORMER CONFORMED NAME: EXPRESSION DIAGNOSTICS INC DATE OF NAME CHANGE: 20030203 4/A 1 wk-form4a_1712698919.xml FORM 4/A X0508 4/A 2024-02-01 2024-02-05 0 0001217234 CareDx, Inc. CDNA 0001617150 Johnson Alexander L C/O CAREDX, INC. 8000 MARINA BOULEVARD BRISBANE CA 94005 0 1 0 0 See Remarks 0 Common Stock 2024-02-01 4 A 0 174520 0 A 345533 D This amendment is being filed to report the grant of restricted stock units which was inadvertently omitted from the original Form 4 filed on February 5, 2024. This resulted in an additional 174,520 shares deemed beneficially owned by the Reporting Person which were inadvertently omitted from the original Form 4 and were also omitted from one Form 4 filed by the Reporting Person on February 6, 2024, which Form 4 should therefore have reflected a total of 344,413 shares deemed beneficially owned in Table I, Column 5. The reported securities are represented by restricted stock units, 1/12th of which shall vest on May 1, 2024 and 1/12th of which shall vest on each date that is three months thereafter. President of Patient and Testing Services /s/ Alexander L. Johnson 2024-04-09